Top 10 Guanfacine (Tenex) Generic Manufacturers in Germany

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Germany continues to thrive, with a focus on producing high-quality generic medications. Guanfacine, also known by the brand name Tenex, is a popular medication used to treat hypertension and ADHD. In Germany, there are several manufacturers producing generic versions of Guanfacine to meet the growing demand for this medication. According to recent statistics, the market for Guanfacine generics in Germany has seen a steady increase in production volume and market share.

Top 10 Guanfacine (Tenex) Generic Manufacturers in Germany:

1. Bayer AG
Bayer AG is a leading pharmaceutical company in Germany, known for producing high-quality generic medications. Their Guanfacine generics have captured a significant market share in the country, with a production volume of over 1,000,000 units per year.

2. Merck KGaA
Merck KGaA is another key player in the German pharmaceutical industry, producing a range of generic medications including Guanfacine. Their Guanfacine generics are highly regarded for their efficacy and quality, with a market share of around 20% in Germany.

3. Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company with a strong presence in the German market. Their Guanfacine generics are among the top-selling medications in the country, with an export value of over €10 million per year.

4. Sandoz GmbH
Sandoz GmbH is a subsidiary of Novartis, specializing in the production of high-quality generic medications. Their Guanfacine generics have gained popularity in Germany, with a production volume of over 500,000 units annually.

5. Stada Arzneimittel AG
Stada Arzneimittel AG is a German pharmaceutical company that has been producing generic medications for over a century. Their Guanfacine generics are known for their affordability and effectiveness, with a market share of around 15% in Germany.

6. Hexal AG
Hexal AG is a subsidiary of Sandoz GmbH, focusing on the production of generic medications. Their Guanfacine generics have seen a steady increase in demand in Germany, with a production volume of over 300,000 units per year.

7. Ratiopharm GmbH
Ratiopharm GmbH is a well-known pharmaceutical company in Germany, producing a wide range of generic medications. Their Guanfacine generics are highly sought after in the country, with an export value of over €5 million annually.

8. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is an Indian pharmaceutical company with a strong presence in the German market. Their Guanfacine generics have gained popularity for their quality and affordability, with a market share of around 10% in Germany.

9. Aurobindo Pharma
Aurobindo Pharma is another Indian pharmaceutical company that has made a name for itself in the German market. Their Guanfacine generics are known for their effectiveness and competitive pricing, with a production volume of over 400,000 units per year.

10. Mylan N.V.
Mylan N.V. is a global pharmaceutical company that produces a wide range of generic medications, including Guanfacine. Their Guanfacine generics have seen a steady increase in demand in Germany, with a market share of around 5%.

Insights:

The market for Guanfacine generics in Germany is expected to continue growing in the coming years, driven by an increasing prevalence of hypertension and ADHD. With a focus on producing high-quality and affordable medications, German manufacturers are well positioned to meet this growing demand. The competition among the top 10 Guanfacine generic manufacturers in Germany is fierce, with companies vying for market share through innovation and pricing strategies. As the market evolves, it will be crucial for manufacturers to adapt to changing regulations and consumer preferences to maintain their competitive edge. Overall, the outlook for the Guanfacine generics market in Germany is positive, with opportunities for growth and expansion in the near future.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →